Research | OneLook Acronym Finder |
Serial Number | 98342248 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Jonathan M. Gelchinsky |
Attorney Docket Number | 39957/3542PC |
2024-01-04 | Application Filed |
2024-01-04 | Status: Live/Pending |
2024-01-04 | Transaction Date |
Owner: | Orna Therapeutics, Inc. |
Address | 500 Forge Road Watertown DE 02472 |
Legal Entity Type | Corporation |
Legal Entity State | DE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 052,051,005,018,006,044,046 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical preparations for the treatment and prevention of autoimmune, immune mediated, and inflammatory diseases and disorders, nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment and prevention of autoimmune, immune mediated, and inflammatory diseases and disorders; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; therapeutic vaccines; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; therapeutic pharmaceutical for the treatment of autoimmune, immune mediated, and inflammatory diseases and disorders, nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment and prevention of autoimmune, immune mediated, and inflammatory diseases and disorders |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED | 2024-01-04 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2024-04-22 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2024-08-01 | 3 DOCK D:Assigned to Examiner |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2024-08-01 | 4 CNSA P: |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2024-08-14 | 5 NONP E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.